(May 31, 2024, 9:19 AM EDT) -- BOSTON — A Massachusetts medical device company has agreed to pay $42 million and plead guilty in a deferred prosecution agreement to resolve claims that it misled consumers and the U.S. Food and Drug Administration by concealing a malfunction in the company’s lead tests that produced inaccurately low test results....